Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mateusz Szymański, Sandra Chmielewska, Urszula Czyżewska, Marta Malinowska & Adam Tylicki. (2022) Echinocandins – structure, mechanism of action and use in antifungal therapy. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 876-894.
Read now
Read now
Joseph Berthier, Mehdi Benmameri, François-Ludovic Sauvage, Gabin Fabre, Benjamin Chantemargue, Hélène Arnion, Pierre Marquet, Patrick Trouillas, Nicolas Picard & Franck Saint-Marcoux. (2021) MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood. Xenobiotica 51:1, pages 105-114.
Read now
Read now
Seyed MohammadReza Hashemian, Tayebeh Farhadi & Ali Akbar Velayati. (2020) Caspofungin: a review of its characteristics, activity, and use in intensive care units. Expert Review of Anti-infective Therapy 18:12, pages 1213-1220.
Read now
Read now
Siang Fei Yeoh, Tae Jin Lee, Ka Lip Chew, Stephen Lin, Dennis Yeo & Sajita Setia. (2018) Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infection and Drug Resistance 11, pages 805-819.
Read now
Read now
Javier Martínez-Casanova, Nuria Carballo, Sonia Luque, Luisa Sorli & Santiago Grau. (2018) Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis. Infection and Drug Resistance 11, pages 317-321.
Read now
Read now
Ya-Lin Chang, Shang-Jie Yu, Joseph Heitman, Melanie Wellington & Ying-Lien Chen. (2017) New facets of antifungal therapy. Virulence 8:2, pages 222-236.
Read now
Read now
Articles from other publishers (27)
Yazed S Alsowaida, Ahmad Alamer, Abrar K Thabit, Abdulaziz S Almulhim, Muneerah M Aleissa, Alireza Kalbasi, Khaled Eljaaly, Thamer A Almangour & Brian L Erstad. (2023) Echinocandin exposures in obese patients: A scoping review and clinical perspectives. American Journal of Health-System Pharmacy 80:8, pages 503-517.
Crossref
Crossref
Qianting Yang, Tao Zhang, Ying Zhang, Dan Sun, Xiaowei Zheng, Qian Du, Xue Wang, Xiaoliang Cheng, Jianfeng Xing & Yalin Dong. (2022) The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations. Frontiers in Pharmacology 13.
Crossref
Crossref
Faruk Ekinci, Dincer Yildizdas, Ozden Ozgur Horoz, Ozlem Ozgur Gundeslioglu & Derya Alabaz. (2022)
Treatment of
Candida
urinary tract infections with micafungin in children
. Pediatrics International 64:1.
Crossref
Crossref
Pekka Ylipalosaari, Tero I. Ala‐Kokko, Juha Koskenkari, Jouko J. Laurila, Sirpa Ämmälä & Hannu Syrjälä. (2021) Use and outcome of empiric echinocandins in critically ill patients. Acta Anaesthesiologica Scandinavica 65:7, pages 944-951.
Crossref
Crossref
Philipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, Sharon C A Chen, Arnaldo Lopes Colombo, Martin Hoenigl, Nikolay Klimko, Cornelia Lass-Flörl, Rita O Oladele, Donald C Vinh, Li-Ping Zhu, Boris Böll, Roger Brüggemann, Jean-Pierre Gangneux, John R Perfect, Thomas F Patterson, Thorsten Persigehl, Jacques F Meis, Luis Ostrosky-Zeichner, P Lewis White, Paul E Verweij & Oliver A Cornely. (2021) Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. The Lancet Infectious Diseases 21:6, pages e149-e162.
Crossref
Crossref
Shubai Zhong, Xu Zhu, Limei Zhao, Yan Song, Jian Yu, Zhen Zheng & Bin Zang. (2021) Optimization of Micafungin Dosage for Chinese Patients with Sepsis in the Intensive Care Unit Based on a Population Pharmacokinetic-Pharmacodynamic Analysis. Pharmaceutical Research 38:1, pages 67-77.
Crossref
Crossref
Alberto Ferrarese, Annamaria Cattelan, Umberto Cillo, Enrico Gringeri, Francesco Paolo Russo, Giacomo Germani, Martina Gambato, Patrizia Burra & Marco Senzolo. (2020) Invasive fungal infection before and after liver transplantation. World Journal of Gastroenterology 26:47, pages 7485-7496.
Crossref
Crossref
Xiaoqing Liu, Dongdong Liu, Ying Pan & Yimin Li. (2020) Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 45:6, pages 1207-1217.
Crossref
Crossref
A. Gómez-López. (2020) Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation. Clinical Microbiology and Infection 26:11, pages 1481-1487.
Crossref
Crossref
Bing Zhu, Yuanzhen Dong, Jie Ma, Minwei Chen, Sida Ruan, Wenjie Zhao & Jun Feng. (2020) The synthesis and activity evaluation of N‐acylated analogs of echinocandin B with improved solubility and lower toxicity. Journal of Peptide Science 26:11.
Crossref
Crossref
Qianting Yang, Tao Zhang, Dan Zhao, Ying Zhang, Yuzhu Dong, Dan Sun, Qian Du, Jing Zheng, Haidong Lu & Yalin Dong. (2019) Factors influencing caspofungin plasma concentrations in kidney transplant patients with high incidence of invasive fungal infections. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 72-80.
Crossref
Crossref
Christian Koch, Emmanuel Schneck, Christoph Arens, Melanie Markmann, Michael Sander, Michael Henrich, Markus A. Weigand & Christoph Lichtenstern. (2019) Hemodynamic changes in surgical intensive care unit patients undergoing echinocandin treatment. International Journal of Clinical Pharmacy 42:1, pages 72-79.
Crossref
Crossref
Laura Ferreras-Antolín, Adam Irwin, Ayad Atra, Alicia Dermirjian, Simon B. Drysdale, Marieke Emonts, Paddy McMaster, Stephane Paulus, Sanjay Patel, Sally Kinsey, Stefania Vergnano, Elisabeth Whittaker & Adilia Warris. (2019) Neonatal Antifungal Consumption Is Dominated by Prophylactic Use; Outcomes From The Pediatric Antifungal Stewardship. The Pediatric Infectious Disease Journal 38:12, pages 1219-1223.
Crossref
Crossref
Ashrit Multani, Aruna K. Subramanian & Anne Y. Liu. (2019)
Successful eradication of chronic symptomatic
Candida krusei
urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature
. Transplant Infectious Disease 21:4.
Crossref
Crossref
P. Marie Arockianathan, Monika Mishra & Rituraj Niranjan. (2019) Recent Status and Advancements in the Development of Antifungal Agents: Highlights on Plant and Marine Based Antifungals. Current Topics in Medicinal Chemistry 19:10, pages 812-830.
Crossref
Crossref
Christian Koch, Jennifer Jersch, Emmanuel Schneck, Fabian Edinger, Hagen Maxeiner, Florian Uhle, Markus A. Weigand, Melanie Markmann, Michael Sander & Michael Henrich. (2018) Caspofungin Modulates Ryanodine Receptor-Mediated Calcium Release in Human Cardiac Myocytes. Antimicrobial Agents and Chemotherapy 62:11.
Crossref
Crossref
Qian-ting Yang, Ya-jing Zhai, Lu Chen, Tao Zhang, Yan Yan, Ti Meng, Lei-chao Liu, Li-mei Chen, Xue Wang & Ya-lin Dong. (2018) Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients. Acta Pharmacologica Sinica 39:9, pages 1533-1543.
Crossref
Crossref
Nicolas Venisse. 2018. Pharmacologie des Anti-Infectieux. Pharmacologie des Anti-Infectieux
121
126
.
Roger J. M. Brüggemann, Dylan W. de Lange & Jan-Willem C. Alffenaar. 2018. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill
213
238
.
Marianna Ventura, Roberta Michelini, Nunzia Decembrino, Mariadelfina Molinaro, Marco Zecca & Simona De Gregori. (2017) High Performance Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Quantification of Caspofungin, Anidulafungin and Micafungin in Human Plasma for Feasible Applications in Pediatric Haematology/Oncology. Chromatographia 80:7, pages 1035-1045.
Crossref
Crossref
C. C. Chang, M. A. Slavin & S. C.-A. Chen. (2017) New developments and directions in the clinical application of the echinocandins. Archives of Toxicology 91:4, pages 1613-1621.
Crossref
Crossref
Tyson E. Dietrich, Carolyn J. Pfeifer, Kelsey E. Aker & Scott J. Bergman. (2017) Antifungal Dosing Strategies for Critically Ill Patients. Current Fungal Infection Reports 11:1, pages 5-15.
Crossref
Crossref
Vincent J. C. Lempers, Jeroen J. M. W. van den Heuvel, Frans G. M. Russel, Rob E. Aarnoutse, David M. Burger, Roger J. Brüggemann & Jan B. Koenderink. (2016) Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrobial Agents and Chemotherapy 60:6, pages 3372-3379.
Crossref
Crossref
Vincent J. Lempers & Roger J. Brüggemann. (2016) Antifungal therapy: drug–drug interactions at your fingertips. Journal of Antimicrobial Chemotherapy 71:2, pages 285-289.
Crossref
Crossref
Christian Koch, Matthias Wolff, Michael Henrich, Markus A. Weigand, Christoph Lichtenstern & Florian Uhle. (2016) Cardiac Effects of Echinocandins in Endotoxemic Rats. Antimicrobial Agents and Chemotherapy 60:1, pages 301-306.
Crossref
Crossref
Tara Anderson. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity
97
107
.
Vincent JC Lempers, Lisa C Martial, Michiel F Schreuder, Nicole M Blijlevens, David M Burger, Rob E Aarnoutse & Roger JM Brüggemann. (2015) Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice. Current Opinion in Pharmacology 24, pages 38-44.
Crossref
Crossref